Telehealth: The Regulatory Frontier

In response to the COVID-19 pandemic, governments across the United States relaxed restrictions on telemedicine, allowing more patients to receive healthcare remotely than ever before.

This development brought a number of questions about how telehealth should be regulated to the fore. Is remote care as effective as in-person care? Would long-term expansion of telemedicine reduce costs for patients and healthcare providers? Might a greater reliance on telehealth actually reduce access to care for some patients?

In this Fourth Branch video, medical professionals and legal experts examine the debates over these questions and more.

Ateev Mehrotra

Associate Professor of Health Care Policy

Department of Health Care Policy, Harvard Medical School


Carrie Nixon

Co-Founder and Managing Partner

Nixon Gwilt Law


Sebastian Seiguer

CEO and Co-Founder

Emocha Health


FDA & Health
State & Local

The Federalist Society and Regulatory Transparency Project take no position on particular legal or public policy matters. All expressions of opinion are those of the speaker(s). To join the debate, please email us at rtp@regproject.org.

Get RTP content in your inbox!

Sign up now to stay up-to-date on all RTP content and events.

  • This field is for validation purposes and should be left unchanged.